Search

Your search keyword '"Yinggan Zheng"' showing total 28 results

Search Constraints

Start Over You searched for: Author "Yinggan Zheng" Remove constraint Author: "Yinggan Zheng" Topic myocardial infarction Remove constraint Topic: myocardial infarction
28 results on '"Yinggan Zheng"'

Search Results

1. Ticagrelor or clopidogrel dual antiplatelet therapy following a pharmacoinvasive strategy in <scp>ST</scp> ‐segment elevation myocardial infarction

2. Association between glycated haemoglobin levels and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the <scp>TECOS</scp> randomized clinical trial

3. Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS

4. Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision Medicine

5. Procedural Volume and Outcomes After Primary Percutaneous Coronary Intervention for ST‐Segment–Elevation Myocardial Infarction in Kerala, India: Report of the Cardiological Society of India–Kerala Primary Percutaneous Coronary Intervention Registry

6. Relationship between community hospital versus pre-hospital location of randomisation and clinical outcomes in ST-elevation myocardial infarction patients: insights from the Stream study

7. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction in Clinical Practice

8. Associations between beta-blocker therapy and cardiovascular outcomes in patients with diabetes and established cardiovascular disease

9. Implications of ischaemic area at risk and mode of reperfusion in ST-elevation myocardial infarction

10. Relationships Between Baseline Q Waves, Time From Symptom Onset, and Clinical Outcomes in ST-Segment-Elevation Myocardial Infarction Patients: Insights From the Vital Heart Response Registry

11. An assessment of ST-segment measurement variability between two core electrocardiogram laboratories

12. APPLICATION OF TICAGRELOR OR CLOPIDOGREL BASED DUAL ANTIPLATELET THERAPY FOLLOWING A PHARMACOINVASIVE STRATEGY IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE VITAL HEART RESPONSE REGISTRY

13. Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarction

14. Baseline Q waves as a prognostic modulator in patients with ST-segment elevation: insights from the PLATO trial

15. Providing Rapid Out of Hospital Acute Cardiovascular Treatment 4 (PROACT‐4)

16. Infarct Size, Shock, and Heart Failure: Does Reperfusion Strategy Matter in Early Presenting Patients With ST‐Segment Elevation Myocardial Infarction?

17. Baseline Q waves and time from symptom onset to ST-segment elevation myocardial infarction: insights from PLATO on the influence of sex

18. REAL WORLD RELATIONSHIPS BETWEEN BASELINE Q WAVES, TIME FROM SYMPTOM ONSET AND CLINICAL OUTCOMES IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION PATIENTS: INSIGHT FROM THE VITAL HEART RESPONSE REGISTRY

19. Corrigendum to 'Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the Strategic Reperfusion Early After Myocardial infarction trial' [Am Heart J 169/6 (2015) 890–898]

20. Applying novel methods to assess clinical outcomes: insights from the TRILOGY ACS trial

21. Aborted myocardial infarction in ST-elevation myocardial infarction: insights from the STrategic Reperfusion Early After Myocardial infarction trial

22. Prognostic implications of quantitative evaluation of baseline Q-wave width in ST-segment elevation myocardial infarction

23. Variations in practice and outcomes in patients undergoing primary percutaneous coronary intervention in the United States and Canada: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI) trial

24. RELATIONSHIP BETWEEN ARTERIAL ACCESS AND OUTCOMES IN A PHARMACOINVASIVE VERSUS PRIMARY PCI STRATEGY IN ST-ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION (STREAM) STUDY

25. Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the STrategic Reperfusion Early After Myocardial infarction trial

26. MYOCARDIAL INFARCT SIZE AND SHOCK/HEART FAILURE: DOES REPERFUSION STRATEGY MATTER IN EARLY PRESENTING STEMIS?

27. Implications of ischaemic area at risk and mode of reperfusion in ST-elevation myocardial infarction.

28. Aborted myocardial infarction in ST-elevation myocardial infarction: insights from the STrategic Reperfusion Early After Myocardial infarction trial.

Catalog

Books, media, physical & digital resources